Net Cash Provided by (Used in) Financing Activities in USD of VYCOR MEDICAL INC from 2013 to Q1 2025

Taxonomy & unit
us-gaap: USD and EUR
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Vycor Medical Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2013 to Q1 2025.
  • Vycor Medical Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was -$17.7K, a 10.7% decline year-over-year.
  • Vycor Medical Inc annual Net Cash Provided by (Used in) Financing Activities for 2024 was -$7.55K, a 3680% decline from 2023.
  • Vycor Medical Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $211.000, a 99.9% decline from 2022.
  • Vycor Medical Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $166K, a 168% increase from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

VYCOR MEDICAL INC Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$17.7K -$1.71K -10.7% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-15
Q1 2024 -$16K -$1.84K -13% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-15
Q1 2023 -$14.1K -$82.5K -121% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2022 $68.4K +$17.3K +33.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q1 2021 $51.1K -$27.7K -35.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q1 2020 $78.9K +$39.2K +98.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q1 2019 $39.7K -$15.5K -28% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q1 2018 $55.2K -$764K -93.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q1 2017 $819K +$845K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q1 2016 -$25.8K -$487 -1.92% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q1 2015 -$25.3K -$3.87M -101% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-28
Q1 2014 $3.85M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15

VYCOR MEDICAL INC Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$7.55K -$7.77K -3680% Jan 1, 2024 Dec 31, 2024 10-K 2025-04-15
2023 $211 -$166K -99.9% Jan 1, 2023 Dec 31, 2023 10-K 2025-04-15
2022 $166K +$104K +168% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-16
2021 $61.9K -$225K -78.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-14
2020 $287K +$246K +615% Jan 1, 2020 Dec 31, 2020 10-K 2022-04-13
2019 $40.1K -$160K -80% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 $200K -$663K -76.8% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-27
2017 $864K +$597K +224% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-29
2016 $267K +$352K Jan 1, 2016 Dec 31, 2016 10-K 2018-03-30
2015 -$85.3K -$4.81M -102% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-31
2014 $4.73M +$3.64M +334% Jan 1, 2014 Dec 31, 2014 10-K 2015-03-31
2013 $1.09M Jan 1, 2013 Dec 31, 2013 10-K 2015-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.